University of Maryland lab supplies donated to local hospitals – WTOP

Posted on by

Two University of Maryland students noticed that there were a lot of useful items in local labs that could be used for health care workers fighting coronavirus.

Two University of Maryland students noticed that there were a lot of useful items in local labs that could be used for health care workers fighting coronavirus, and decided to do something about it.

We do have some of this equipment so it only made sense just to get it to the right places that need it immediately, said Christina Conrad, a Ph.D. student in the Department of Bioengineering at the University of Maryland.

Conrad, along with fellow student James Shamul, sent an email to their department to see if there were items in their labs that could be donated to those caring for patients during the coronavirus outbreak.

Conrad said the response was overwhelming.

From there, we started reaching out to the entire university.

Thirty-seven different labs including animal science, biology, physics and other departments replied and donated more than 24,000 pairs of gloves, 2,500 face masks, 137 disposable lab coats, more than 100 N95 masks, and multiple gallons of cleaning supplies.

Its been really just exciting to get a lot of generosity. A lot of people have come together, Conrad said.

They have donated the supplies to the Prince Georges County Heath Department, the University of Maryland Medical Center, Johns Hopkins and the Greater Baltimore Medical Center.

Its definitely a great way for me to spend my time right now since our labs are closed at Maryland, Conrad said. A lot of us Ph.D. students are focused on writing our dissertations or reading literature, so this has just been a really great activity to be involved and try to make a difference.

More Coronavirus News

Like WTOP on Facebook and follow @WTOP on Twitter to engage in conversation about this article and others.

Get breaking news and daily headlines delivered to your email inbox by signing up here.

2020 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

See the original post:
University of Maryland lab supplies donated to local hospitals - WTOP

Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients – New Haven Register

Posted on by

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients

NEW HAVEN Health care workers and COVID-19 patients at Yale New Haven Hospital are being tested to see if those exposed to the coronavirus have developed antibodies to the disease and what effect those antibodies have on the body.

The tests, designed by Yale University scientists, will help better explain how COVID-19 spreads and how widely the coronavirus has spread, according to a release. Health care workers who have developed antibodies may have developed immunity and be able to care for COVID-19 patients without fear that they will be infected again.

We want to know what proportion of people were infected and if antibodies protect you from re-infection once you come out of lockdown, said Dr. Albert Ko, chairman of the Yale School of Public Healths Department of Epidemiology.

The test has not been approved for general use in patients. Giving the test to hospitalized COVID-19 patients will help establish accuracy, the release said. Researchers hope the tests will help determine whether antibodies to the coronavirus, SARS-CoV-2, give immunity to COVID-19 or whether they may worsen the illness.

The concern is that antibodies in some cases can trigger an immune response known as a cytokine storm. Ko and team are also investigating whether antibodies against the SARS-CoV-2 virus can in some cases be harmful by helping trigger the devastating cytokine storm immune response that can fill lungs with fluid and cause heart and kidney failure, the release said.

Cytokines are proteins created by cells, including interferons and interleukins, which may be overproduced and result in excess fluid in the lungs. It is considered a likely cause of deaths in the 1918 flu pandemic, according to Physicians Weekly.

Understanding the quality of a patients antibody response is therefore very important in giving assurance that a person is immune, said Aaron Ring, assistant professor of immunobiology, in the release. Also, if harmful antibody responses can be identified, this may suggest new therapeutic strategies for COVID-19.

While the Food and Drug Administration is expected to approve antibody tests this week, the lack of tests has slowed the ability to investigate the development of antibodies. Ko, Ring and others began using tests developed at Yale. Hundreds of health care workers and COVID-19 patients have been tested and new tests are being developed to check whether antibodies are being produced in response to other viral proteins, the release said.

Antibodies are the part of the bodys response to infection. The flu virus produces antibodies, but there are different strains of the flu, and antibodies are only effective against one strain. On the other hand, antibodies also are created by exposure to the common cold, also a coronavirus,

One key question they hope to answer is whether antibodies generated by COVID-19 actually prevent re-infection, as they do against strains of flu virus. If so, policymakers may be able to relax social distancing guidelines for those who possess these antibodies, and allow them to re-enter the workforce. However, antibodies created after exposure to the common cold, which is also a coronavirus, do not protect from being exposed again. Not all antibodies are created equal, Ko said.

We need to know what drives protective responses to the virus to help spur vaccine development, Ko said.

Other members of the research team included Dr. Camila Odio, associate research scientist Arnau Casanovas Massana and bioengineering graduate student Feimei Liu.

See the rest here:
Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients - New Haven Register

Intelligent Design and COVID-19: Take a Seat for This Criticism – Discovery Institute

Posted on by

Image: Fusion Medical Animation,viaUnsplash.

I have been replying to criticisms of ID scientists by historian Adam Shapiro (see here and here). You had better take a seat for Shapiros next assertion:

.. there has been no indication that the government has looked to intelligent design research nor consulted any intelligent designfavoring scientists to address the pandemic On May 4, National Institute of Allergy and Infectious Diseases Director Anthony Fauci gave aninterviewin which he stated: A number of very qualified evolutionary biologists have said that everything about the stepwise evolution over time strongly indicates that it [the SARS-CoV-2 virus] evolved in nature and then jumped species.

But, of course, every scientist who has addressed the question of design or no design in the COVID-19 virus has been doing intelligent design research. Anderson et al. (2020) used a benchmark for known specific methods of human bioengineering, compared the spike protein to that benchmark, and found that it fell short. Surely more work remains to be done, but if that wasnt ID reasoning, what is?

These scientists are using the principle of fine-tuning to assess the viral genome for markers of complex specified information that could not be present without human intervention. All questions about the possibility of human-designed origin of COVID are intelligent design questions. And these scientists, who are doing excellent implicit design research, draw conclusions about the design of the virus based on the evidence to which they have access, which is considerably more than the limited evidence that, again as far as I am personally aware, the small cadre of explicit ID scientists have available to them.

In keeping with the best tradition of intelligent design research, which comprises most biological research since antiquity, ID researchers are staying within the bounds of the evidence available to them. They refrain from drawing conclusions scientific in form but political in nature based on insufficient evidence. ID, Adam Shapiro thinks, could redeem itself as being apolitical precisely by playing politics with science. It is remarkable indeed that Dr. Shapiro a historian of science berates ID scientists for not reaching conclusions in the absence of adequate evidence while he fails to recognize the mountain of intelligent design research being conducted on the origin of COVID-19 in leading laboratories all over the world.

Continue reading here:
Intelligent Design and COVID-19: Take a Seat for This Criticism - Discovery Institute

Stanford researchers tackle COVID-19 from all angles – The Stanford Daily

Posted on by

Stanford researchers across disciplines and departments have launched research projects to tackle the COVID-19 pandemic and its effects on daily life with a wide range of approaches.

Scientists, physicians and engineers are collaborating to find drugs and vaccines for the disease, combat personal protective equipment (PPE) and ventilator shortages, test existing therapeutics in nationwide clinical trials and optimize the productivity of the work-from-home workforce.

Here, we highlight a few of many Stanford research projects.

Searching for therapeutics

Research to find treatments for COVID-19 has focused on discovering antibodies to enable peoples immune systems to fend off the virus that causes COVID-19, known as SARS-CoV-2, and finding drugs that target viral proteins or human cells that help the virus spread.

Toward the first aim, in late January, genetics M.D./Ph.D. student Binbin Chen and his colleagues started a project to identify fragments of SARS-CoV-2 that can be used for COVID-19 vaccines.

Vaccines are one of the most powerful tools to curb a pandemic and prevent its recurrence, Chen said. However, vaccine design is often a guessing game with new pathogens so artificial intelligence tools built upon immunology knowledge and data can provide a better educated guess and increase the chances of finding an effective vaccine.

Chen and his co-authors have made a list of vaccine candidates available in a bioRxiv preprint in an effort to help bring vaccines to the clinic. They are also organizing a long-term project to collect patient samples for future pandemics.

In the midst of the pandemic, Chen found many willing and readily accessible collaborators. Some of those volunteering to help out were from across the globe. A senior author of one of the first SARS-CoV-2 protein structure papers from China replied to Chens email within four hours. And, in addition to international help, Chen found assistance much closer to home.

I also live with one on my academic collaborators my husband so we get a lot done! Chen said.

Stefano Rensi Ph.D. 18, a research engineer in the bioengineering department, has taken a different approach to the problem of finding therapeutics: Repurpose existing drugs with the goal of getting them to the front lines as soon as possible.

Rensi and colleagues including bioengineering professor Russ Altman Ph.D. 89 M.D. 90 predicted that existing compounds can bind and inhibit a key protein transmembrane protease, serine 2 (TMPRSS2) that facilitates viral invasion of human cells.

Feeling a sense of urgency, Rensi has put other projects on hold to help out with the crisis. He believes others in the Stanford community and around the world have done the same.

People across institutions and industry are all sharing information, ideas and results, Rensi said. I cant think of any better use of our time or training than fighting a global pandemic.

As computational researchers, Rensi and his co-authors now collaborate with others to test their predicted compounds in experimental assays, or tests, to see if their drugs can inhibit the key enzyme required for the virus to enter and infect human cells.

If [the assays] pan out, we will advance to animal testing and then clinical trials, Rensi said.

Starting rapid, adaptive clinical trials

Others, including Kari Nadeau, professor of medicine and pediatrics, and Neera Ahuja, clinical professor of medicine, have worked to bring clinical trials sponsored by the National Institutes of Health (NIH) to Stanford.

Nadeau and Ahuja are spearheading a trial at Stanford that is also being conducted at 64 other sites globally to test the safety and efficacy of remdesivir in hospitalized adult patients diagnosed with COVID-19. Remdesivir is a novel antiviral drug originally developed as a treatment for Ebola; it mimics a building block of viral genetic material and works to prevent viral replication.

The goal of the collaboration between Nadeau, Ahuja and the NIH is to quickly make more treatment options available for COVID-19 patients.

In very rapid form, we were able to get the trial up, site-approved and open for enrollment in about a week, which is really unheard of, Ahuja said.

Nadeau was excited to be able to work with the NIH and expressed gratitude for physicians like Ahuja, who are balancing patient care with the coordination of new clinical trials to obtain much-needed data on therapies for COVID-19.

Because there is no current therapy, we should be compelled to be a part of the best clinical trials out there, Nadeau said.

Nadeau also pointed out that clinical trials must be designed to anticipate the potential genetic mutations of SARS-CoV-2, as viruses can gain resistance to single therapies, often necessitating combinations of multiple drugs.

There are methodologies in statistics and trial design adaptive trial design where you can combine more than one drug at a time, Nadeau said. Viruses are super smart and can develop resistance. So, we are going to start an adaptive trial design for combination therapies.

Coping with working from home

Researchers like Pablo Paredes, a radiology and psychiatry and behavioral services instructor, are working on solutions to alleviate the added stress for many people who are now being asked to work from home while balancing family life.

Paredes and his collaborators are developing web-based tools specifically a Google Chrome extension and mobile app to support healthy routines for productivity, reduce over-consumption of stressful media and web content, and encourage work-life balance and family interaction.

The project, called Home Sweet Office (HSO), integrates mental health and stress management interventions created in Paredess lab, the Pervasive Wellbeing Technology Lab, with a former project from the lab of Michael Bernstein, associate professor of computer science.

We believe the new normal of human-human interaction will demand new ways of thinking and new tools for productivity, stress and mental health, Paredes said.

HSO aims not only to create tools to increase mental health and stress management, but also aggregate critical data for the future.

The data generated will serve towards studying the longitudinal causal relationships between stress, productivity, and mental health, Paredes said.

Contact Yash Pershad at ypershad at stanford.edu.

Here is the original post:
Stanford researchers tackle COVID-19 from all angles - The Stanford Daily

Bioreactors and Fermentors Market Growing Popularity and Trends in the Global Industry 2020| Bioengineering AG, Applikon Biotechnology, Pall…

Posted on by

Los Angeles, United State: QY Research recently published a research report titled, Global Bioreactors and Fermentors Market Research Report 2020 The research report is collated on the basis of historic and forecast data derived by using primary and secondary methodologies by researchers. The global Bioreactors and Fermentors market is one of the fastest-growing markets and is expected to witness substantial growth in the forecast years. Reader are provided easy access to thorough analysis on the various aspects such as opportunities and restraints affecting the market. The Bioreactors and Fermentors report clearly explains the trajectory this market will take in the forecast years.

The Bioreactors and Fermentors research report has presented an analysis of various factors influencing the markets current growth. Drivers, restraints, and trends are elaborated to understand their positive or negative effects. This Bioreactors and Fermentors report section is aimed at providing readers with a thorough information about the potential scope of various applications and segments. These estimates are based on the current trends and historic milestones.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)@https://www.qyresearch.com/sample-form/form/1760939/covid-19-impact-on-bioreactors-and-fermentors-market

This section of the Bioreactors and Fermentors report offers a thorough and comprehensive information about the various manufacturers in the market. The major manufacturers covered in the report hold significant share that demands a microscopic look. It provides vital information about various strategies implemented by these manufacturers to combat competition and expand their footprint in the Bioreactors and Fermentors market. It also surveys the current trends adopted by the manufacturers to innovate their product for the future. This Bioreactors and Fermentors report is structured in such a way so as to help the reader understand the market and make business decisions accordingly.

Key Players Mentioned in the Global Bioreactors and Fermentors Market Research Report:

Bioengineering AG, Applikon Biotechnology, Pall Corporation, GE Healthcare, Sartorius AG, Eppendorf, Thermo Fisher Scientific, Cellexus, Celltainer Biotech BV, Finesse Solutions, Merck Millipore, PBS Biotech, Cellution Biotech, CerCell ApS, Electrolab Biotech, Infors AG, Pierre Guerin, Techniserv, Broadley-Jamesn

Global Bioreactors and Fermentors Market Segmentation by Product:Single-use BioreactorsMultiple-use Bioreactors

Global Bioreactors and Fermentors Market Segmentation by Application:Food IndustryPharmaceuticalSewage TreatmentBiochemical EngineeringOthers

The Bioreactors and Fermentors Market research report briefs on segments such as product type and end users. The product type segment gives an understanding about various products available in the Bioreactors and Fermentors market. It also gives information on what is the scope and potential of each product. Also, the segment presents an elaborate information on end users. Understanding end users is of utmost importance as it aids in identifying marketable areas.

Key questions answered in the report: What is the growth potential of the Bioreactors and Fermentors market? Which product segment will grab a lions share? Which regional market will emerge as a frontrunner in coming years? Which application segment will grow at a robust rate? What are the growth opportunities that may emerge in Bioreactors and Fermentors industry in the years to come? What are the key challenges that the global Bioreactors and Fermentors market may face in future? Which are the leading companies in the global Bioreactors and Fermentors market? Which are the key trends positively impacting the market growth? Which are the growth strategies considered by the players to sustain hold in the global Bioreactors and Fermentors market?

Request for customization in Report:@https://www.qyresearch.com/customize-request/form/1760939/covid-19-impact-on-bioreactors-and-fermentors-market

Table od Content:1.1 Research Scope1.2 Market Segmentation1.3 Research Objectives1.4 Research Methodology1.4.1 Research Process1.4.2 Data Triangulation1.4.3 Research Approach1.4.4 Base Year1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections1.5.2 Covid-19 Impact: Commodity Prices Indices1.5.3 Covid-19 Impact: Global Major Government Policy1.6 The Covid-19 Impact on Bioreactors and Fermentors Industry1.7 COVID-19 Impact: Bioreactors and Fermentors Market Trends

2 Global Bioreactors and Fermentors Quarterly Market Size Analysis2.1 Bioreactors and Fermentors Business Impact Assessment COVID-192.1.1 Global Bioreactors and Fermentors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.1.2 Global Bioreactors and Fermentors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.2 Global Bioreactors and Fermentors Quarterly Market Size 2020-20212.3 COVID-19-Driven Market Dynamics and Factor Analysis2.3.1 Drivers2.3.2 Restraints2.3.3 Opportunities2.3.4 Challenges

3 Quarterly Competitive Assessment, 20203.1 Global Bioreactors and Fermentors Quarterly Market Size by Manufacturers, 2019 VS 20203.2 Global Bioreactors and Fermentors Factory Price by Manufacturers3.3 Location of Key Manufacturers Bioreactors and Fermentors Manufacturing Factories and Area Served3.4 Date of Key Manufacturers Enter into Bioreactors and Fermentors Market3.5 Key Manufacturers Bioreactors and Fermentors Product Offered3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Bioreactors and Fermentors Segments, By Type4.1 Introduction1.4.1 Single-use Bioreactors1.4.2 Multiple-use Bioreactors4.2 By Type, Global Bioreactors and Fermentors Market Size, 2019-20214.2.1 By Type, Global Bioreactors and Fermentors Market Size by Type, 2020-20214.2.2 By Type, Global Bioreactors and Fermentors Price, 2020-2021

5 Impact of Covid-19 on Bioreactors and Fermentors Segments, By Application5.1 Overview5.5.1 Food Industry5.5.2 Pharmaceutical5.5.3 Sewage Treatment5.5.4 Biochemical Engineering5.5.5 Others5.2 By Application, Global Bioreactors and Fermentors Market Size, 2019-20215.2.1 By Application, Global Bioreactors and Fermentors Market Size by Application, 2019-20215.2.2 By Application, Global Bioreactors and Fermentors Price, 2020-2021

6 Geographic Analysis6.1 Introduction6.2 North America6.2.1 Macroeconomic Indicators of US6.2.2 US6.2.3 Canada6.3 Europe6.3.1 Macroeconomic Indicators of Europe6.3.2 Germany6.3.3 France6.3.4 UK6.3.5 Italy6.4 Asia-Pacific6.4.1 Macroeconomic Indicators of Asia-Pacific6.4.2 China6.4.3 Japan6.4.4 South Korea6.4.5 India6.4.6 ASEAN6.5 Rest of World6.5.1 Latin America6.5.2 Middle East and Africa

7 Company Profiles7.1 Bioengineering AG7.1.1 Bioengineering AG Business Overview7.1.2 Bioengineering AG Bioreactors and Fermentors Quarterly Production and Revenue, 20207.1.3 Bioengineering AG Bioreactors and Fermentors Product Introduction7.1.4 Bioengineering AG Response to COVID-19 and Related Developments7.2 Applikon Biotechnology7.2.1 Applikon Biotechnology Business Overview7.2.2 Applikon Biotechnology Bioreactors and Fermentors Quarterly Production and Revenue, 20207.2.3 Applikon Biotechnology Bioreactors and Fermentors Product Introduction7.2.4 Applikon Biotechnology Response to COVID-19 and Related Developments7.3 Pall Corporation7.3.1 Pall Corporation Business Overview7.3.2 Pall Corporation Bioreactors and Fermentors Quarterly Production and Revenue, 20207.3.3 Pall Corporation Bioreactors and Fermentors Product Introduction7.3.4 Pall Corporation Response to COVID-19 and Related Developments7.4 GE Healthcare7.4.1 GE Healthcare Business Overview7.4.2 GE Healthcare Bioreactors and Fermentors Quarterly Production and Revenue, 20207.4.3 GE Healthcare Bioreactors and Fermentors Product Introduction7.4.4 GE Healthcare Response to COVID-19 and Related Developments7.5 Sartorius AG7.5.1 Sartorius AG Business Overview7.5.2 Sartorius AG Bioreactors and Fermentors Quarterly Production and Revenue, 20207.5.3 Sartorius AG Bioreactors and Fermentors Product Introduction7.5.4 Sartorius AG Response to COVID-19 and Related Developments7.6 Eppendorf7.6.1 Eppendorf Business Overview7.6.2 Eppendorf Bioreactors and Fermentors Quarterly Production and Revenue, 20207.6.3 Eppendorf Bioreactors and Fermentors Product Introduction7.6.4 Eppendorf Response to COVID-19 and Related Developments7.7 Thermo Fisher Scientific7.7.1 Thermo Fisher Scientific Business Overview7.7.2 Thermo Fisher Scientific Bioreactors and Fermentors Quarterly Production and Revenue, 20207.7.3 Thermo Fisher Scientific Bioreactors and Fermentors Product Introduction7.7.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments7.8 Cellexus7.8.1 Cellexus Business Overview7.8.2 Cellexus Bioreactors and Fermentors Quarterly Production and Revenue, 20207.8.3 Cellexus Bioreactors and Fermentors Product Introduction7.8.4 Cellexus Response to COVID-19 and Related Developments7.9 Celltainer Biotech BV7.9.1 Celltainer Biotech BV Business Overview7.9.2 Celltainer Biotech BV Bioreactors and Fermentors Quarterly Production and Revenue, 20207.9.3 Celltainer Biotech BV Bioreactors and Fermentors Product Introduction7.9.4 Celltainer Biotech BV Response to COVID-19 and Related Developments7.10 Finesse Solutions7.10.1 Finesse Solutions Business Overview7.10.2 Finesse Solutions Bioreactors and Fermentors Quarterly Production and Revenue, 20207.10.3 Finesse Solutions Bioreactors and Fermentors Product Introduction7.10.4 Finesse Solutions Response to COVID-19 and Related Developments7.11 Merck Millipore7.11.1 Merck Millipore Business Overview7.11.2 Merck Millipore Bioreactors and Fermentors Quarterly Production and Revenue, 20207.11.3 Merck Millipore Bioreactors and Fermentors Product Introduction7.11.4 Merck Millipore Response to COVID-19 and Related Developments7.12 PBS Biotech7.12.1 PBS Biotech Business Overview7.12.2 PBS Biotech Bioreactors and Fermentors Quarterly Production and Revenue, 20207.12.3 PBS Biotech Bioreactors and Fermentors Product Introduction7.12.4 PBS Biotech Response to COVID-19 and Related Developments7.13 Cellution Biotech7.13.1 Cellution Biotech Business Overview7.13.2 Cellution Biotech Bioreactors and Fermentors Quarterly Production and Revenue, 20207.13.3 Cellution Biotech Bioreactors and Fermentors Product Introduction7.13.4 Cellution Biotech Response to COVID-19 and Related Developments7.14 CerCell ApS7.14.1 CerCell ApS Business Overview7.14.2 CerCell ApS Bioreactors and Fermentors Quarterly Production and Revenue, 20207.14.3 CerCell ApS Bioreactors and Fermentors Product Introduction7.14.4 CerCell ApS Response to COVID-19 and Related Developments7.15 Electrolab Biotech7.15.1 Electrolab Biotech Business Overview7.15.2 Electrolab Biotech Bioreactors and Fermentors Quarterly Production and Revenue, 20207.15.3 Electrolab Biotech Bioreactors and Fermentors Product Introduction7.15.4 Electrolab Biotech Response to COVID-19 and Related Developments7.16 Infors AG7.16.1 Infors AG Business Overview7.16.2 Infors AG Bioreactors and Fermentors Quarterly Production and Revenue, 20207.16.3 Infors AG Bioreactors and Fermentors Product Introduction7.16.4 Infors AG Response to COVID-19 and Related Developments7.17 Pierre Guerin7.17.1 Pierre Guerin Business Overview7.17.2 Pierre Guerin Bioreactors and Fermentors Quarterly Production and Revenue, 20207.17.3 Pierre Guerin Bioreactors and Fermentors Product Introduction7.17.4 Pierre Guerin Response to COVID-19 and Related Developments7.18 Techniserv7.18.1 Techniserv Business Overview7.18.2 Techniserv Bioreactors and Fermentors Quarterly Production and Revenue, 20207.18.3 Techniserv Bioreactors and Fermentors Product Introduction7.18.4 Techniserv Response to COVID-19 and Related Developments7.19 Broadley-Jamesn7.19.1 Broadley-Jamesn Business Overview7.19.2 Broadley-Jamesn Bioreactors and Fermentors Quarterly Production and Revenue, 20207.19.3 Broadley-Jamesn Bioreactors and Fermentors Product Introduction7.19.4 Broadley-Jamesn Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis8.1 Bioreactors and Fermentors Supply Chain Analysis8.1.1 Bioreactors and Fermentors Supply Chain Analysis8.1.2 Covid-19 Impact on Bioreactors and Fermentors Supply Chain8.2 Distribution Channels Analysis8.2.1 Bioreactors and Fermentors Distribution Channels8.2.2 Covid-19 Impact on Bioreactors and Fermentors Distribution Channels8.2.3 Bioreactors and Fermentors Distributors8.3 Bioreactors and Fermentors Customers

9 Key Findings

10 Appendix10.1 About Us10.2 Disclaimer

About Us:QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

See the original post:
Bioreactors and Fermentors Market Growing Popularity and Trends in the Global Industry 2020| Bioengineering AG, Applikon Biotechnology, Pall...

Feed Microecologics Market 2020 Segmented Analysis by Product Types, Applications, Key Players and Regions Forecast 2026 | Liaoning Huaxing,…

Posted on by

LOS ANGELES, United States:

The report titled, Global Feed Microecologics Market is recently published by QY Research. The analysts and researchers have performed primary as well as secondary research on a large scale with the help of various methodologies like Porters Five Forces and PESTLE Analysis.

Get the Sample of this Report with Detail TOC and List of [emailprotected]https://www.qyresearch.com/sample-form/form/1896392/global-feed-microecologics-market

Key trends and opportunities that may emerge in the near future have been discussed in the report. A detailed analysis of the factors positively influencing the growth has been done by the professionals. Besides, factors that may act as key challenges for the participants are examined in the report.

Players having a strong presence are investigated in the report. Competitive scenario is also looked over by inspecting the key business strategies considered by the vendors to sustain their hold. This complete analysis will definitely act as an effective tool for the manufacturers to gain an insight into the overall present and future scenario and accordingly plan their strategies:

Key Players:

Liaoning Huaxing, Cerbios-Pharma SA, Angel Yeast, Alpharma, Guangdong Haid Group, Guangdong Xi Pu Group, Shandong Boly-lely Bioengineering, KDN Biotech Group, Lallemand, Da Bei Nong Group, Suzhou Branch Animal Husbandry

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Feed Microecologics Market which would mention How the Covid-19 is Affecting the Feed Microecologics Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Feed Microecologics Players to Combat Covid-19 Impact.

To further widen the understanding, the authors of the report have studied the key segments including product type, end use, and application. This breakdown is based on parameters like size, share, CGAR, production, and consumption. Additionally, regional analysis of the industry is carried out by the analysts to provide the end users with the information regarding the potential regions and their respective countries.

Market Segments Covered:

Global Feed Microecologics Market Segmentation by Product:ProbioticsPrebioticsSynbiotics

Global Feed Microecologics Market Segmentation by Application:PoultryLivestockOther

Regions Covered in the Global Feed Microecologics Market:

The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

What the Report has in Store for you?

Industry Size & Forecast: The industry analysts have offered historical, current, and estimated projections of the industry size from the value and volume point of view Future Opportunities: In this section of the report, Feed Microecologics participants are provided with the information on the future prospects that the Feed Microecologics industry is likely to offer Industry Trends & Developments: Here, authors of the report have talked about the major trends and developments taking place in the Feed Microecologics marketplace and their estimated impact on the overall growth Study on Industry Segmentation: Detailed breakdown of the key Feed Microecologics industry segments including product type, application, and vertical has been done in this portion of the report Regional Analysis: Feed Microecologics vendors are offered crucial information of the high growth regions and their respective countries, thus helping them to invest in profitable regions Competitive Landscape: This unit of the report throws light on the competitive scenario of the Feed Microecologics industry by focusing on the key strategies taken up by the vendors to consolidate their presence in the Feed Microecologics business.

Ask for Customized Report as per Your [emailprotected]https://www.qyresearch.com/customize-request/form/1896392/global-feed-microecologics-market

Important Points Covered in TOC:

1 Feed Microecologics Market Overview1.1 Feed Microecologics Product Overview1.2 Feed Microecologics Market Segment by Type1.2.1 Probiotics1.2.2 Prebiotics1.2.3 Synbiotics1.3 Global Feed Microecologics Market Size by Type (2015-2026)1.3.1 Global Feed Microecologics Market Size Overview by Type (2015-2026)1.3.2 Global Feed Microecologics Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Feed Microecologics Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Feed Microecologics Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Feed Microecologics Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Feed Microecologics Market Size Forecast by Type (2021-2026)1.3.3.1 Global Feed Microecologics Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Feed Microecologics Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Feed Microecologics Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Feed Microecologics Sales Breakdown by Type (2015-2026)1.4.2 Europe Feed Microecologics Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Feed Microecologics Sales Breakdown by Type (2015-2026)1.4.4 Latin America Feed Microecologics Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Feed Microecologics Sales Breakdown by Type (2015-2026)

2 Global Feed Microecologics Market Competition by Company2.1 Global Top Players by Feed Microecologics Sales (2015-2020)2.2 Global Top Players by Feed Microecologics Revenue (2015-2020)2.3 Global Top Players Feed Microecologics Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Feed Microecologics Manufacturing Base Distribution, Sales Area, Product Type2.5 Feed Microecologics Market Competitive Situation and Trends2.5.1 Feed Microecologics Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Feed Microecologics Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Feed Microecologics as of 2019)2.7 Date of Key Manufacturers Enter into Feed Microecologics Market2.8 Key Manufacturers Feed Microecologics Product Offered2.9 Mergers & Acquisitions, Expansion

3 Global Feed Microecologics Status and Outlook by Region (2015-2026)3.1 Global Feed Microecologics Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Feed Microecologics Market Size Market Share by Region (2015-2020)3.2.1 Global Feed Microecologics Sales Market Share by Region (2015-2020)3.2.2 Global Feed Microecologics Revenue Market Share by Region (2015-2020)3.2.3 Global Feed Microecologics Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Feed Microecologics Market Size Market Share by Region (2021-2026)3.3.1 Global Feed Microecologics Sales Market Share by Region (2021-2026)3.3.2 Global Feed Microecologics Revenue Market Share by Region (2021-2026)3.3.3 Global Feed Microecologics Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Feed Microecologics Market Size YoY Growth (2015-2026)3.4.1 North America Feed Microecologics Revenue YoY Growth (2015-2026)3.4.2 North America Feed Microecologics Sales YoY Growth (2015-2026)3.5 Asia-Pacific Feed Microecologics Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Feed Microecologics Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Feed Microecologics Sales YoY Growth (2015-2026)3.6 Europe Feed Microecologics Market Size YoY Growth (2015-2026)3.6.1 Europe Feed Microecologics Revenue YoY Growth (2015-2026)3.6.2 Europe Feed Microecologics Sales YoY Growth (2015-2026)3.7 Latin America Feed Microecologics Market Size YoY Growth (2015-2026)3.7.1 Latin America Feed Microecologics Revenue YoY Growth (2015-2026)3.7.2 Latin America Feed Microecologics Sales YoY Growth (2015-2026)3.8 Middle East and Africa Feed Microecologics Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Feed Microecologics Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Feed Microecologics Sales YoY Growth (2015-2026)

4 Global Feed Microecologics by Application4.1 Feed Microecologics Segment by Application4.1.1 Poultry4.1.2 Livestock4.1.3 Other4.2 Global Feed Microecologics Sales by Application: 2015 VS 2020 VS 20264.3 Global Feed Microecologics Historic Sales by Application (2015-2020)4.4 Global Feed Microecologics Forecasted Sales by Application (2021-2026)4.5 Key Regions Feed Microecologics Market Size by Application4.5.1 North America Feed Microecologics by Application4.5.2 Europe Feed Microecologics by Application4.5.3 Asia-Pacific Feed Microecologics by Application4.5.4 Latin America Feed Microecologics by Application4.5.5 Middle East and Africa Feed Microecologics by Application5 North America Feed Microecologics Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Feed Microecologics Sales Market Share by Country (2015-2020)5.1.2 North America Feed Microecologics Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Feed Microecologics Sales Market Share by Country (2021-2026)5.2.2 North America Feed Microecologics Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Feed Microecologics Market Size YoY Growth (2015-2026)5.3.2 Canada Feed Microecologics Market Size YoY Growth (2015-2026)6 Europe Feed Microecologics Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Feed Microecologics Sales Market Share by Country (2015-2020)6.1.2 Europe Feed Microecologics Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Feed Microecologics Sales Market Share by Country (2021-2026)6.2.2 Europe Feed Microecologics Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Feed Microecologics Market Size YoY Growth (2015-2026)6.3.2 France Feed Microecologics Market Size YoY Growth (2015-2026)6.3.3 U.K. Feed Microecologics Market Size YoY Growth (2015-2026)6.3.4 Italy Feed Microecologics Market Size YoY Growth (2015-2026)6.3.5 Russia Feed Microecologics Market Size YoY Growth (2015-2026)7 Asia-Pacific Feed Microecologics Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Feed Microecologics Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Feed Microecologics Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Feed Microecologics Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Feed Microecologics Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Feed Microecologics Market Size YoY Growth (2015-2026)7.3.2 Japan Feed Microecologics Market Size YoY Growth (2015-2026)7.3.3 South Korea Feed Microecologics Market Size YoY Growth (2015-2026)7.3.4 India Feed Microecologics Market Size YoY Growth (2015-2026)7.3.5 Australia Feed Microecologics Market Size YoY Growth (2015-2026)7.3.6 Taiwan Feed Microecologics Market Size YoY Growth (2015-2026)7.3.7 Indonesia Feed Microecologics Market Size YoY Growth (2015-2026)7.3.8 Thailand Feed Microecologics Market Size YoY Growth (2015-2026)7.3.9 Malaysia Feed Microecologics Market Size YoY Growth (2015-2026)7.3.10 Philippines Feed Microecologics Market Size YoY Growth (2015-2026)7.3.11 Vietnam Feed Microecologics Market Size YoY Growth (2015-2026)8 Latin America Feed Microecologics Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Feed Microecologics Sales Market Share by Country (2015-2020)8.1.2 Latin America Feed Microecologics Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Feed Microecologics Sales Market Share by Country (2021-2026)8.2.2 Latin America Feed Microecologics Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Feed Microecologics Market Size YoY Growth (2015-2026)8.3.2 Brazil Feed Microecologics Market Size YoY Growth (2015-2026)8.3.3 Argentina Feed Microecologics Market Size YoY Growth (2015-2026)9 Middle East and Africa Feed Microecologics Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Feed Microecologics Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Feed Microecologics Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Feed Microecologics Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Feed Microecologics Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Feed Microecologics Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Feed Microecologics Market Size YoY Growth (2015-2026)9.3.3 UAE Feed Microecologics Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in Feed Microecologics Business10.1 Liaoning Huaxing10.1.1 Liaoning Huaxing Corporation Information10.1.2 Liaoning Huaxing Description, Business Overview and Total Revenue10.1.3 Liaoning Huaxing Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.1.4 Liaoning Huaxing Feed Microecologics Products Offered10.1.5 Liaoning Huaxing Recent Development10.2 Cerbios-Pharma SA10.2.1 Cerbios-Pharma SA Corporation Information10.2.2 Cerbios-Pharma SA Description, Business Overview and Total Revenue10.2.3 Cerbios-Pharma SA Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.2.4 Liaoning Huaxing Feed Microecologics Products Offered10.2.5 Cerbios-Pharma SA Recent Development10.3 Angel Yeast10.3.1 Angel Yeast Corporation Information10.3.2 Angel Yeast Description, Business Overview and Total Revenue10.3.3 Angel Yeast Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.3.4 Angel Yeast Feed Microecologics Products Offered10.3.5 Angel Yeast Recent Development10.4 Alpharma10.4.1 Alpharma Corporation Information10.4.2 Alpharma Description, Business Overview and Total Revenue10.4.3 Alpharma Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.4.4 Alpharma Feed Microecologics Products Offered10.4.5 Alpharma Recent Development10.5 Guangdong Haid Group10.5.1 Guangdong Haid Group Corporation Information10.5.2 Guangdong Haid Group Description, Business Overview and Total Revenue10.5.3 Guangdong Haid Group Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.5.4 Guangdong Haid Group Feed Microecologics Products Offered10.5.5 Guangdong Haid Group Recent Development10.6 Guangdong Xi Pu Group10.6.1 Guangdong Xi Pu Group Corporation Information10.6.2 Guangdong Xi Pu Group Description, Business Overview and Total Revenue10.6.3 Guangdong Xi Pu Group Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.6.4 Guangdong Xi Pu Group Feed Microecologics Products Offered10.6.5 Guangdong Xi Pu Group Recent Development10.7 Shandong Boly-lely Bioengineering10.7.1 Shandong Boly-lely Bioengineering Corporation Information10.7.2 Shandong Boly-lely Bioengineering Description, Business Overview and Total Revenue10.7.3 Shandong Boly-lely Bioengineering Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.7.4 Shandong Boly-lely Bioengineering Feed Microecologics Products Offered10.7.5 Shandong Boly-lely Bioengineering Recent Development10.8 KDN Biotech Group10.8.1 KDN Biotech Group Corporation Information10.8.2 KDN Biotech Group Description, Business Overview and Total Revenue10.8.3 KDN Biotech Group Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.8.4 KDN Biotech Group Feed Microecologics Products Offered10.8.5 KDN Biotech Group Recent Development10.9 Lallemand10.9.1 Lallemand Corporation Information10.9.2 Lallemand Description, Business Overview and Total Revenue10.9.3 Lallemand Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.9.4 Lallemand Feed Microecologics Products Offered10.9.5 Lallemand Recent Development10.10 Da Bei Nong Group10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Feed Microecologics Product Category, Application and Specification10.10.3 Da Bei Nong Group Feed Microecologics Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Da Bei Nong Group Recent Development10.11 Suzhou Branch Animal Husbandry10.11.1 Suzhou Branch Animal Husbandry Corporation Information10.11.2 Suzhou Branch Animal Husbandry Description, Business Overview and Total Revenue10.11.3 Suzhou Branch Animal Husbandry Feed Microecologics Sales, Revenue and Gross Margin (2015-2020)10.11.4 Suzhou Branch Animal Husbandry Feed Microecologics Products Offered10.11.5 Suzhou Branch Animal Husbandry Recent Development

11 Feed Microecologics Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Feed Microecologics Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Feed Microecologics Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Industry Trends11.4.2 Market Drivers11.4.3 Market Challenges11.4.4 Porters Five Forces Analysis

12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:QY Research, INC.17890 Castleton, Suite 218,Los Angeles, CA 91748USA: +1 626 428 8800India: +91 9766 478 224Email [emailprotected]Web http://www.qyresearch.com

Read the original post:
Feed Microecologics Market 2020 Segmented Analysis by Product Types, Applications, Key Players and Regions Forecast 2026 | Liaoning Huaxing,...

How COVID-19 is Impacting the Industrial Bioprocessing Market by Industry Analysis, by Type, Application and Top Players:BD Biosciences, BioPharm…

Posted on by

Note: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Industrial BioprocessingMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Industrial Bioprocessing Market Players to battle Covid-19 Impact.

The Industrial BioprocessingMarket report is compilation of intelligent, broad research studies that will help players and stakeholders to make informed business decisions in future. It offers detailed research and analysis of key aspects of the Industrial Bioprocessing market. Readers will be able to gain deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the global Industrial Bioprocessing market. Buyers of the report will have access to accurate PESTLE, SWOT and other types of analysis on the global Industrial Bioprocessing market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Industrial Bioprocessing markets to extend their reach and create sales opportunities.

The study encompasses profiles of major Companies/Manufacturers operating in the global Industrial Bioprocessing Market.Key players profiled in the report include:BD Biosciences, BioPharm International, GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius Stedim Biotech, Merck Millipore, 3M Company, Eppendorf AG, Finesse Solutions, Applikon Biotechnology B.V., Cesco Bioengineering and More

Get PDF Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/145292

Segmental Analysis:The report has classified the global Industrial Bioprocessing market into segments including product type and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Industrial Bioprocessing manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, there by helping market players to gain deep insights into the overall Industrial Bioprocessing industry.

Key Types:Upstream BioprocessingDownstream Bioprocessing

Key End-Use:FoodMedicalPharmaceuticals and NutraceuticalsChemicalsFuelsOthers

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/145292

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Industrial Bioprocessing market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Industrial Bioprocessing industry to help players plan effective expansion strategies.

Regions Covered in the Global Industrial Bioprocessing Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025

For More Information:https://www.marketinforeports.com/Market-Reports/145292/Industrial-Bioprocessing-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/145292/Industrial-Bioprocessing-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]Website: http://www.marketinforeports.com

See the rest here:
How COVID-19 is Impacting the Industrial Bioprocessing Market by Industry Analysis, by Type, Application and Top Players:BD Biosciences, BioPharm...

NIH recruiting 10K adults for coronavirus infection study – ModernHealthcare.com

Posted on by

NEW YORK The National Institutes of Health have started recruiting for a new study that aims to determine how many adults in the U.S. who have not had a confirmed infection with SARS-CoV-2 carry antibodies to the virus, indicating that they were previously infected.

The study, called "SARS-CoV-2 Pandemic Serosurvey and Blood Sampling," is conducted by the National Institute of Allergy and Infectious Diseases and the National Institute of Biomedical Imaging and Bioengineering, with additional support from the National Center for Advancing Translational Sciences and the National Cancer Institute. The researchers plan to collect and analyze blood samples from up to 10,000 volunteers.

"This study will give us a clearer picture of the true magnitude of the COVID-19 pandemic in the United States by telling us how many people in different communities have been infected without knowing it, because they had a very mild, undocumented illness or did not access testing while they were sick," said NIAID Director Anthony Fauci in a statement. "These crucial data will help us measure the impact of our public health efforts now and guide our COIVD-19 response moving forward."

The investigators plan to analyze blood samples for two types of antibodies, anti-SARS-CoV-2 S protein IgG and IgM, using an enzyme-linked immunosorbent assay (ELISA) developed at NIAID and NIBIB. Participants with positive test results may undergo additional tests to evaluate their immune response to the virus. The results may explain why these cases were less severe than those that resulted in hospitalization.

Healthy adults over the age of 18 from across the US who have no confirmed history of COVID-19 and have no current symptoms are eligible to participate and will be enrolled over the phone.

Study participants working at the NIH Bethesda campus will have their blood drawn at the NIH Clinical Center, while other volunteers will take their own blood samples at home, using at-home blood collection kits provided by Neoteryx, a medical device firm based in Torrance, California.

"Researchers have considerable experience using these at-home blood collection kits to track the spread of other infectious diseases like influenza, and this method is safe, effective and easy-to-use," said Kaitlyn Sadtler, study lead for laboratory testing and chief of NIBIB's section for immunoengineering, in a statement.

More information about the study is available here.

This article was originally published in our sister publication Genomeweb.

Originally posted here:
NIH recruiting 10K adults for coronavirus infection study - ModernHealthcare.com

Global Evaporated Vegetable Market 2020 Insights, Share, Growth and Future Trends Cole Reports – Cole of Duty

Posted on by

Los Angeles, United States, May 2020: The Evaporated Vegetable market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Researchs latest publication, Titled [Evaporated Vegetable Market Research Report 2020-2026], offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the Evaporated Vegetable market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market. A team subject-matter experts have provided the readers a qualitative and quantitative data about the market and the various elements associated with it.

QY research recently published a report, titled Global Evaporated Vegetable Market Insights, Forecast to 2025. The research includes collation of data that is gathered using primary and secondary research methodologies. The research is conducted by professionals who have remarkable expertise in the field. The report elaborates on all the aspect of the market for a comprehensive understanding of the market dynamics. The market is divided into various segments and all the segments follow a similar format for a detailed explanation of the market.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1697434/covid-19-impact-on-global-evaporated-vegetable-market

The researchers have studied the global Evaporated Vegetable market taking into account key aspects such as market trends and dynamics, opportunities, segmentation including product and application, market participants, and competitive landscape. The report analytically studies microeconomic and macroeconomic factors affecting the global Evaporated Vegetable market growth. Additionally, the report on the global Evaporated Vegetable market lays down a precise forecast of the contribution of the product and application segment types to the growth of the Evaporated Vegetable market size. The regional analysis gives a clear cut understanding to the readers pertaining to the present and future situations of the global Evaporated Vegetable market. This detailed analysis can surely help the clients in planning their business strategies and staying ahead of the curve.

For Further Detailed insights and Any Query About Evaporated Vegetable Market, Place your Query Here!- https://www.qyresearch.com/customize-request/form/1697434/covid-19-impact-on-global-evaporated-vegetable-market

Table of Contents

1 Evaporated Vegetable Market Overview1.1 Evaporated Vegetable Product Overview1.2 Evaporated Vegetable Market Segment by Type1.2.1 Cloud Service Orchestration1.2.2 API Management1.2.3 Application Integration1.2.4 B2B and Cloud Integration1.2.5 Data Integration1.3 Global Evaporated Vegetable Market Size by Type1.3.1 Global Evaporated Vegetable Sales and Growth by Type1.3.2 Global Evaporated Vegetable Sales and Market Share by Type (2014-2019)1.3.3 Global Evaporated Vegetable Revenue and Market Share by Type (2014-2019)1.3.4 Global Evaporated Vegetable Price by Type (2014-2019)

2 Global Evaporated Vegetable Market Competition by Company2.1 Global Evaporated Vegetable Sales and Market Share by Company (2014-2019)2.2 Global Evaporated Vegetable Revenue and Share by Company (2014-2019)2.3 Global Evaporated Vegetable Price by Company (2014-2019)2.4 Global Top Players Evaporated Vegetable Manufacturing Base Distribution, Sales Area, Product Types2.5 Evaporated Vegetable Market Competitive Situation and Trends2.5.1 Evaporated Vegetable Market Concentration Rate2.5.2 Global Evaporated Vegetable Market Share of Top 5 and Top 10 Players2.5.3 Mergers & Acquisitions, Expansion

Continued..

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

View post:
Global Evaporated Vegetable Market 2020 Insights, Share, Growth and Future Trends Cole Reports - Cole of Duty

Technology and ethics in the coronavirus economy – TechCrunch

Posted on by

Javier Saade serves on several boards, is venture partner at Fenway Summer and is a senior advisor at FS Vector, Fenway Summers advisory affiliate. Previously, he was associate administrator and chief of investment and innovation at SBA.

The last two decades have ushered in significant change and transformation. I believe the 2020s will be dispositive in redefining the pillars of our economy, and COVID-19 magnifies this greatly. As of this writing there are 3,611,394 confirmed cases, and the U.S. accounts for 33% of those. We are now dealing with a 4.8% Q1 GDP contraction and expectations for Q2s shrinking runs into the 25% range, more than 30 million unemployed and a $7 trillion federal intervention in a span of six weeks.

Eric Schmidt recently predicted that the coronavirus pandemic is strengthening big tech. It is hard to disagree with him; it almost feels obvious. Big tech and other digital companies are net beneficiaries of new habits and behaviors. Some of this shift will be permanent, and well-capitalized tech companies are likely to expand their power by grabbing talent and buying companies for their IP then dissolving them.

With power comes political backlash and public wariness. One flavor of that counter pressure is already in full effect. Sen. Elizabeth Warren and Rep. Alexandria Ocasio-Cortez have proposed new legislation that seeks to curtail acquisition activity via the Pandemic Anti-Monopoly Act. Ill reserve judgment on their effort, but the theme is familiar: the strong get stronger and the weak get weaker, which further widens gaps and calcifies disparity.

The COVID-19 shock is highlighting a chasm that has evolved over decades. The digital divide, lack of capital access, sporadic paths to education and microscopic levels of wealth accumulation in communities of color and the implicit/explicit bias against non-coastal elites are some contributing factors.

During the 2008 crisis, the combined value of the five biggest companies ExxonMobil, General Electric, Microsoft, AT&T and Procter & Gamble was $1.6 trillion. Microsoft is worth almost that today all by itself. No need to talk about FAANG, because since the pandemics economic halt, Peloton downloads went up five-fold in a month, Zoom grew to 200 million users from 10 million in December and Instacart users grew six times in that period.

Roelof Botha of Sequoia Capital was recently quoted as saying, Like the killing off of the dinosaurs, this reorders who gets to survive in the new era. It is the shock that accelerates the future that Silicon Valley has been building. It is hard to argue with his views.

To be clear, I am a beneficiary of and a big believer in technology. Throughout my career I have managed it, invested in it and made policy on it. For example, one of the multi-billion-dollar programs I oversaw, the Small Business Innovation Research (SBIR) program, has invested more than $50 billion in tens of thousands of startups, which have collectively issued 70,000 patents and raised hundreds of billions of capital and 700 of them have gone public, including tech titans such as Qualcomm, Biogen and Symantec.

My point: I think about technology a lot, and, lately, about its repercussions. There is a massive shift afoot where more power and influence will be consolidated by these remarkable companies and their technology. Besides the economic consequences of the strong crushing the weak, there are serious ethical issues to consider as a society. Chamath Palihapitiya has been pretty vocal about the moral hazard of what is essentially a massive transfer of wealth and income. On one side you have mismanaged and/or myopic corporations and on the other, the counterparty is the American people and the money we need to print to bankroll the lifeline. I am not talking about Main Street here, by the way.

It is not hard to imagine a world in which tech alone reigns supreme. The ethical dilemmas of this are vast. A recent documentary, Do You Trust this Computer, put a spotlight on a frantic Elon Musk ringing the alarm bell on machines potential to destroy humanity. Stephen Hawking argued that while artificial intelligence could provide society with outsized benefits, it also has the potential to spiral out of control and end the human race. Bill Gates has been less fatalistic, but is also in the camp of those concerned with synthetic intelligence. In an interesting parallel, Bill has for years been very vocal on the risks pandemics pose and our lack of preparedness for them indeed.

These three men have had a big impact on the world with and because of technology. Their deep concern is rooted in the fact that once the genie is out of the bottle, it will make and grant wishes to itself without regard to humanity. But, is this doomsday thinking? I dont know. What I do know is that I am not alone thinking about this. With COVID-19 as a backdrop, many people are.

Algorithmic sophistication and computer horsepower continue to evolve by leaps and bounds, and serious capital continues to be invested on these fronts. The number of transistors per chip has increased from thousands in the 1950s to over four billion today. A one-atom transistor is the physical boundary of Moores Law. Increasing the amount of information conveyed per unit, say with quantum computing, is the most realistic possibility of extending Moores Law, and with it the march toward intelligent machines and a tech first world. The march has been accelerated, even if peripherally, by the pandemic.

While the promise of technology-driven progress is massive, there are some serious societal costs to exponential discovery and unleashed capability acceleration. Dartmouths Dr. James Moor, a notable thinker at the intersection of ethics and technology, believes that the use and development of technologies are most important when technologies have transformative effects on societies. He stipulates that as the impact of technology grows, the volume and complexity of ethical issues surrounding it increases. This is not only because more people are touched by these innovations, they are. It is because transformative technology increases pathways of action that outstrip governance systems and ethical constructs to tame it.

So what? The twists and turns of technology application lead to consequences, sometimes unknowable and for that reason we should be increasingly vigilant. Did Zuckerberg ever imagine that his invention would have been so central to the outcome of the 2016 election? Unknowable consequences, exhibit one. Interconnected systems touch every aspect of society, from digital terrorism to bioengineering to brain hacking and neural cryonics to swarm warfare, digital assets, intelligent weapons, trillions of IoT connected devices the list goes on.

As a society, we should be open to innovation and the benefits it ushers in. At the same time, we must also remain committed to sustainable tech development and a deployment mechanism that does not fail to shine a light on human dignity, economic inequality and broad inclusiveness. These seem like esoteric issues, but they are not, and they are being put to the test by COVID-19.

A fresh example of this thematic happened recently: Tim Bray, a VP and engineer at Amazons AWS, resigned because of the companys treatment of employees, and was quoted as saying, in part, Amazon treats the humans in the warehouses as fungible units of pick-and-pack potential. Only thats not just Amazon, its how 21st-century capitalism is done If we dont like certain things Amazon is doing, we need to put legal guardrails in place to stop those things.

Eliminating human agency has been at the core of innovation during the last four decades. Less human intervention in a call center, a hedge fund trading desk, a factory, a checkout line or a motor vehicle seems fine but in cases of greater importance, humans should remain more active or we will, at best, make ourselves irrelevant. In the past, labor displacement has been temporary, but it seems to me that the next wave is likely to be different in terms of the permanence of labor allocation, and big tech getting bigger will likely hasten this.

Innovative capability has been at the center of progress and living standard improvements since we harnessed fire. The worlds technology portfolio is an exciting one, but potentially terrifying to those who could be more hampered by it, such as the front-line workers on Main Street shouldering the health and economic brunt of the coronavirus.

Years ago, Peter Drucker pointed out that technology has transformed from servant to master throughout our history. Regarding the assembly line, he noted that it does not use the strengths of the human being but, instead, subordinated human strengths to the requirements of the machine.

In my opinion, Druckers quote is at the very core of our point in time, happening on a scale and speed that is hard to fathom and changing the digital divide amongst us into a digital canyon between us and technology.

See the rest here:
Technology and ethics in the coronavirus economy - TechCrunch

Symptom-trackers and doctor dorms: how universities are fighting Covid-19 – The Guardian

Posted on by

Universities are right on the frontline in the battle against coronavirus. Theyre loaning the NHS vital medical equipment and facilities, using 3D printers to produce personal protective equipment, researching potential vaccines, and boosting the NHS workforce with fast-tracked medical students and healthcare academics. But these arent the only ways theyre contributing. Here are a few of the unexpected ways in which universities are using their research and resources to improve peoples lives.

The lack of ventilators is one of the biggest challenges facing the health system during the coronavirus epidemic. But not all patients need a ventilator some can be treated with a breathing aid. University College Londons (UCL) engineering academics have collaborated with Formula One to rapidly develop a device that means ventilators can be saved for those who need them most.

A University of Cambridge team has developed a new test which can diagnose coronavirus in under 90 minutes by identifying traces of the virus genetic material. As well as enabling patients to be quickly triaged, the test can determine which healthcare workers have already been infected. Its currently being rolled out at hospitals in Cambridge before it is launched across the UK.

Worried that youve got coronavirus? Theres an app for that. Developed by researchers at Kings College London, the app asks participants to fill in some of their personal and medical data, then take one minute a day to report on whether they feel healthy and, if not, to answer questions on a wide range of symptoms, from coughs and fever to fatigue, diarrhoea and confusion. The goal is to inform the public as well as provide real-time information on the spread of the illness across the UK.

The coronavirus crisis is likely to put considerable strain on everyones mental health, but the pressure will be even more severe on frontline NHS workers. To tackle this, psychologists at the University of Liverpool have developed targeted mental health resources based on their work with people who have worked in high-stakes situations such as earthquakes, terror attacks and war zones.

The newly created hospital, NHS Nightingale, is located out in east Londons docklands, right next to a University of East London campus. Thats why the university is making its student halls available free of charge to healthcare workers deployed there.

Bristol Robotics Laboratory, the UKs biggest robotics centre, is usually the place scientists go to ponder the complex questions behind bioengineering. But its now deploying its two-wheeled video-conferencing robot to give people real-time art exhibition tours at Hastings Contemporary, an art gallery thats been closed due to coronavirus.

While the public health emergency is what matters most, coronavirus will also have a serious impact on businesses. Teesside University has collaborated with the Tees Valley mayor and the local authority to shore up businesses and help them survive the crisis. The university is helping local businesses shift online as well as providing support to budding digital entrepreneurs.

The lack of protective gear for NHS staff has been widely reported. Thats why staff at the Sir John Cass School of Art, Architecture and Design at London Met have sewn nearly 500 face masks over the past week to be used wherever theyre needed most, from maternity wards in hospitals to homeless shelters. The masks are made following NHS guidelines, and the staff plan to tap into the local sewing community to make hundreds more.

Sitting at home isnt where youd expect to enjoy world-class performing arts, but the Royal Conservatoire of Scotland (RCS) is aiming to shift people stuck at home away from Netflix and towards something more highbrow. Digital platform RCSatHome is offering lunchtime concerts, talks and performances from its staff, students and alumni on demand. The platform will also shortly host a new original musical written and produced by RCS students.

Two vertical farms experimenting with producing bigger, higher quality crops have been based in converted shipping containers at Nottingham Trent University for the past year. Since the outbreak of Covid-19, theyve had a new purpose: the university is boxing up pak choi, spinach, Swiss chard, lettuce, coriander and basil to provide to homeless people.

Here is the original post:
Symptom-trackers and doctor dorms: how universities are fighting Covid-19 - The Guardian

How universities are developing COVID-19 solutions in real time – PBS NewsHour

Posted on by

Dorms are empty and classroom lights are off at the vast majority of Americas colleges and universities, but that hasnt stopped many in academia from jumping in to help try to meet the massive need for innovative treatments, vaccines, personal protection equipment (PPE) and medical devices in the wake of the novel coronavirus pandemic.

Engineers, doctors, scientists, researchers, doctors, and college students across the country have quickly shifted gears and are applying their skills and knowledge to fighting the virus, which has infected more than a million people around the globe. The federal government and most states with stay-at-home orders have designated researchers focused on the outbreak as essential critical infrastructure workers, allowing them to continue working in labs and offices.

A number of schools, including Rice University, the University of Texas, the University of Illinois, and the University of Vermont, have been working on new ventilator designs, a critical need with shortages at many hospitals around the country. Faculty from the University of South Carolina, in collaboration with the medical nonprofit Prisma Health, developed an FDA-approved 3D- printed splitter device called the VESper that can treat two patients on one ventilator. And a team at University of California, Berkeley has modified sleep apnea machines so they can provide respiratory support for noncritical COVID-19 patients.

Given the rapid pace of innovation and, in some cases, the short time from inventors bench to hospital room, ensuring that devices are safe and reliable is a key issue for those on the front lines.

Researchers at academic institutions, non-traditional manufacturers, communities of makers, and individuals are banding together to support and fill local and national needs, an FDA spokesperson wrote in a statement to the PBS NewsHour. The goal [of the FDA] is to enable and empower people to make a positive impact in the ways they are able, while ensuring their efforts and outputs are safe.

The FDAs Center for Devices and Radiological Health the government agency tasked with regulating firms who manufacture medical devices sold in the U.S. is using Emergency Use Authorizations (EUAs) to determine if it is reasonable to believe that the [products] may be effective and that the known and potential benefits outweigh the known and potential risks. The FDA declined to disclose the number of EUA requests it has received in response to the COVID-19.

Here are three more ways universities are contributing to the global virus response.

In the dash to prevent needless deaths, some scientists have postponed or abandoned long-term projects to engage in new coronavirus work. Others, like Matt Whitehill, who is pursuing a doctorate at the University of Washington, have sped up existing projects that might eventually prove helpful. Whitehill and a team of fellow computer scientists and electrical engineering students, along with collaborators at Seattle Childrens Hospital and U.W. Medical Center, are working on a cough-detection app for smart mobile devices.

Photo by Getty Images

Cough-detection research at UW began in 2011. Different teams have chased the technology over the years, but Whitehill says there is now a sense of urgency to deploy it. The COVID-19 outbreak has really expedited some of our timelines because there is such a large need for this technology, Whitehill said.

The goal of the technology, part of a move toward remote patient monitoring (RPM) in health care, is to assist both patients and their medical providers monitor coughing while someone is recovering at home from COVID-19 or other diseases that cause coughing symptoms. The app relies on an algorithm Whitehill and his colleagues developed that can detect cough sounds amid other background noises such as conversations; those coughs are then recorded in the app or the device, and can be kept private or shared with others, including health care providers.

Whitehill says as health care facilities become overwhelmed, some patients are being sent home who would normally recover in the hospital. Health care providers or community organizations may want to have some insight into how those patients are doing when they go home, Whitehill said. Automated remote monitoring allows us to get an insight into whether that patients health condition is improving or deteriorating in an objectively reliable, real time way without needing to make contact with the subjects.

Other groups are also working on cough-detecting technology, but Whitehill says UWs app is unique because its aimed at providing a high level of accuracy and protecting user privacy. Only cough counts are recorded and the data is analyzed on the phone instead of a remote server. The research team is currently seeking volunteers to help improve the app by submitting cough sounds and other vocalizations.

The technology can only monitor cough counts, but Whitehill says eventually he hopes to be able to discriminate between cough types e.g. wet or dry. Because COVID-19 is associated with a dry cough, that kind of information could potentially help health care providers more accurately monitor the condition of COVID-19 patients.

Universities are also joining a number of companies and individual volunteers around the country who are developing new solutions for creating and ramping up production of PPE. Northwestern University, MIT, University of the New Hampshire and Michigan State University are among a number of schools that have started 3D-printed face shield projects.

Stanford University bioengineering associate professor Manu Prakash, whose work has long-focused on innovative, low-cost medical devices, is taking a different approach. In early March, he returned from a trip to Europe, where, he said, he had seen how the coronavirus was taking a toll. Prakash then started an open source project to modify full-face snorkel masks into reusable PPE for health care workers.

Courtesy PrakashLab/Stanford

I was highly concerned about what was going to happen in the PPE context in the U.S., Prakash said. I love diving and I have had a snorkel mask for a long while. So that was the starting point.

Working with a number of collaborators, including Boston Scientific, Medtronics and the University of Utah, Prakashs team developed a 3D-printed filter and injection molded attachment that can be connected to the masks air-intake tube, which is aimed back and away from the face. In their initial design, the team used FDA-approved medical-grade filters that are used in various applications around hospitals but not currently for PPE; recently theyve begun testing other types of filtration systems, including HEPA filters used for industrial purposes.

Prakash says the design, which incorporates a face shield and a respirator in one device, could be helpful to health care workers who typically use separate face shields and masks, if the supplies are available. Face mask shortages have become a widespread problem for health care workers around the country.

Its a very technical challenge because youre talking about [containing] aerosolized droplets that are 300 nanometers (0.3 microns) or smaller, said Prakash, referring to the imperceptible spray of saliva that can come out of someones mouth or nose. Frugal science in this context is about coming up with ways to do things quickly, but still having the highest level of safety standards. You have to be extremely serious about really looking critically at the sets of solutions.

Everyone has a shot of making a contribution, and universities are often where it starts.

In addition to cost, one of the key goals of the project is to ensure the modified snorkel-masks can be reused multiple times safely. Prakash says in the past, more medical products, like elastomeric respirators, were made to be reused over and over again with proper cleaning and decontamination. But our disposable culture has led to more single-use products like N95 masks, and now medical professionals are confronted with the fact that there just arent enough disposable supplies to go around.

The research team has been submerging the masks in solutions of bleach and exposing them to heat, among other approved sterilization methods. Prakash says testing has shown the masks survive common decontamination protocols.

The masks, which have been submitted to the FDA for emergency use authorization, are currently undergoing clinical testing in three hospitals. The team is also shipping 100 more to clinicians for pilot testing and another 1,000 to health care workers around the country who are in urgent need.

The innovation that arguably could have the largest influence on the global COVID-19 response is the development of a vaccine. Of the nearly 80 vaccine candidates now in the works, most are being developed from pharmaceutical companies in the U.S. and abroad. But researchers in academia are also involved in the effort, often building on previous vaccine research. Thats the case for a team at the University of Pittsburgh School of Medicine that worked on vaccines for SARS in 2003 and MERS in 2014; both viruses are closely related to the current coronavirus. Earlier this month, they announced an early-stage vaccine candidate called PittCoVacc in a peer-reviewed paper published by The Lancet. The team is also testing an innovative delivery system for that vaccine: a small patch made with 400 tiny needles made out of dissolvable sugars which are saturated with the vaccine.

Andrea Gambotto, M.D., associate professor of surgery at Pitt, holds a COVID-19 microneedle array vaccine on his fingertip. The 400 tiny antigen-tipped needles poke into the skin to stimulate antibody generation. Photo by UPMC

Dr. Louis Falo, who developed the patch, says one of the benefits of the technology is it doesnt have to be refrigerated. Most vaccines have to be refrigerated from when theyre made, all the way until they are in the patient, Falo said. For underdeveloped countries and global vaccination programs, thats an obstacle. Its really expensive and some places arent even equipped with refrigeration. The patches are very stable at room temperature and I think thats a big plus.

Harvard University public health professor Dr. Barry Bloom, who is not involved in current vaccine research but has been tracking developments, cautions against latching on to any one vaccine candidate or delivery system at this point.

But he says increased collaboration and the speed at which results are now being shared in the scientific world is unprecedented. The diversity of vaccine candidates and other innovations is really exciting, said Dr. Bloom. Everyone has a shot of making a contribution, and universities are often where it starts.

Visit link:
How universities are developing COVID-19 solutions in real time - PBS NewsHour

Scientists race against time to tame pandemic – The Standard

Posted on by

It is scientists against time. With news of more infections and death coming from different parts of the world, there is a global race on who will come up with a vaccine or possible cure for the novel coronavirus.The world is anxious, everyone looking up to the scientists to save them from what is now turning into a serious threat to humanity. From when it was a regional crisis affecting a small town in Wuhan, scientists have been holed up in labs, stretching the hours to find a vaccine to stop the spread of the virus.In China, a team of more than 1,000 scientists has come up with what they think could be the solution. They are treating it as warfare, involving their military medical sciences team.

SEE ALSO :Coronavirus: British scientists close to developing vaccine after tests on mice

For More of This and Other Stories, Grab Your Copy of the Standard Newspaper. Read Now

Do not miss out on the latest news. Join the Standard Digital Telegram channel HERE.

Original post:
Scientists race against time to tame pandemic - The Standard

Heres what researchers at IIT Guwahati are doing to tackle the COVID-19 problem – YourStory

Posted on by

The COVID-19 pandemic has spread to almost all countries around the world, with the number of cases increasing by a bigger margin. Currently, the total number of cases in India has gone up to 753, with 20 deaths reported as per Worldometer. In these testing times, many IITs across India are working on different ways to tackle the virus from developing sanitisers to finding a cure.

A team of researchers at IIT Guwahati, led by Professor Sachin Kumar, Department of Biosciences and Bioengineering, are working towards developing a vaccine, along with developing rapid detection and portable diagnostic kits for different types of viruses and microorganisms.

The team consists of PhD students, MTech students, Junior Research Fellows and Post Doctoral Fellows. Recently, the team had developed a vaccine against Japanese encephalitis and classical swine fever virus, and their research was published in the journals Vaccine and Archives of Virology, respectively. The researchers are trying to learn if they can use the same tool that they had developed for the encephalitis so that it could be used for COVID-19 as well.

And its not just the vaccine that they are working on, but they are also working to develop the first line of protection.

The institute, like many others, has already created hand sanitisers as prescribed by the WHO. These sanitisers are distributed to everyone on the campus, including visitors.

India still has long way to go when it comes to fighting the pandemic, but the consistent research efforts by the many institutions give hope to the cause.

(Edited by Kanishk Singh)

Do you have an interesting story to share? Please write to us at tci@yourstory.com. To stay updated with more positive news, please connect with us on Facebook and Twitter.

How has the coronavirus outbreak disrupted your life? And how are you dealing with it? Write to us or send us a video with subject line 'Coronavirus Disruption' to editorial@yourstory.com

Here is the original post:
Heres what researchers at IIT Guwahati are doing to tackle the COVID-19 problem - YourStory

ALung Technologies has a respiratory device, Hemolung, that can be used in place of ventilators – NEXTpittsburgh

Posted on by

ALung Technologies has a device called the Hemolung Respiratory Assist System that has been getting widespread attention lately as desperate physicians search for ways to treat COVID-19 patients.

The onslaught of coronavirus has created a national ventilator shortage, as patients rely on them in life-threatening situations to blow oxygen into the lungs while removing carbon dioxide.

Hemolung is designed to keep people off ventilators as much as possible. It removes carbon dioxide directly from the blood, like a dialysis machine does for kidneys, and delivers oxygen directly to the blood. It was created to help COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome) patients.

Its currently in clinical trials in the U.S., where it has been used in 36 hospitals, and approved for use in Europe, where it has been used in 32 hospitals in the UK with thousands of patients.

In the U.S., by the way, its been used on a compassionate-use basis, an emergency-use basis, as early as three to four years ago, says Hemolung inventor William Federspiel, co-founder of ALung and professor of bioengineering at Pitts Swanson School of Engineering It was actually done here in Pittsburgh. At UPMC Presbyterian hospital.

It can be an alternative or supplement to ventilators, depending on the patients condition, he notes.

It definitely could be used to treat these COVID-19 patients, says Federspiel. But its important to point out that its not going to be an answer to the ventilator shortage. Its been a challenge to ramp up the production of ventilators. Ford and GM have gotten involved and its still a rough path.

Ventilators can cause damage to the lungs. Hemolung avoids this and doesnt require intubation or sedation, so patients can remain responsive and mobile during treatment.

The company is trying to get approval from the FDA to use the Hemolung under Emergency Use Authorization, says Federspiel. Theyre trying to get that, and then they could treat COVID patients. We hope it will keep them from having to go on mechanical ventilation.

They would be able to be awake, not sedated, could move around, talk and eat. Its a very different patient experience on the Hemolung.

ALung is based in the South Side and employs 33 people.

ALungmedical devicesSouth Side

Go here to read the rest:
ALung Technologies has a respiratory device, Hemolung, that can be used in place of ventilators - NEXTpittsburgh

Ultrafiltration Membrane Market 2019 Growth, Trends, and Forecast 2025 – Instant Tech News

Posted on by

Ultrafiltration Membrane Market

The Global Ultrafiltration Membrane MarketResearch Report Forecast 2019-2025:The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Ultrafiltration Membrane Market. The report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Ultrafiltration Membrane Market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, Manufacturing cost, prices, and other key factors related to the global Market.

Get PDF Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/03011120109/global-ultrafiltration-membrane-market-insights-forecast-to-2025/inquiry?mode=31.

Key Players of the Market:

Asahi Kasei, GE Water & Process Technologies, Evoqua, DOW, Toray, 3M (Membrana), Mitsubishi Rayon, Nitto Denko Corporation, Degremont Technologies, Basf, Synder Filtration, Microdyn-Nadir, Canpure, Pentair(X-Flow), Applied Membranes, CITIC Envirotech, Litree, Origin Water, Tianjin MOTIMO, Zhaojin Motian

Segmentation by product type:

Inorganic Membrane

Organic Membrane

Segmentation by application:

Food & Beverage

Industrial & Municipal

Healthcare & Bioengineering

Seawater Reverse Osmosis

Potable Water Treatment

Full Copy Of Report:

https://www.marketinsightsreports.com/reports/03011120109/global-ultrafiltration-membrane-market-insights-forecast-to-2025?mode=31.

Market Segment by Regions, regional analysis covers 2019-2025:

North America(United States, Canada and Mexico)Europe(Germany, France, UK, Russia and Italy)Asia-Pacific(China, Japan, Korea, India and Southeast Asia)South America(Brazil, Argentina, Colombia etc.)Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Influence of the Ultrafiltration Membrane market report:

-Comprehensive assessment of all opportunities and risk in the Ultrafiltration Membrane market

-Ultrafiltration Membrane market recent innovations and major events

-Detailed study of business strategies for growth of the Ultrafiltration Membrane market-leading players.

-Conclusive study about the growth plot of Ultrafiltration Membrane market for forthcoming years.

-In-depth understanding of Ultrafiltration Membrane market-particular drivers, constraints and major micro markets.

-Favourable impression inside vital technological and market latest trends striking the Ultrafiltration Membrane market.

What are the Ultrafiltration Membrane market factors that are explained in the report?

-Key Strategic Developments:The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools:The Global Ultrafiltration Membrane Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

About Us:-

MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights ReportsPhone: + 1704 266 3234 | +91-750-707-8687[emailprotected]|[emailprotected]

See the rest here:
Ultrafiltration Membrane Market 2019 Growth, Trends, and Forecast 2025 - Instant Tech News

Reshaping stream structure to improve habitats – The Daily Evergreen

Posted on by

Palouse Conservation District details restoration techniques, need for stream complexity

Palouse Conservation District coordinator, Randy Stevens talks about his plan to design a better structural element in streams on Wednesday at Paradise Creek Brewery.

TONY NGUYEN

Palouse Conservation District coordinator, Randy Stevens talks about his plan to design a better structural element in streams on Wednesday at Paradise Creek Brewery.

TONY NGUYEN

TONY NGUYEN

Palouse Conservation District coordinator, Randy Stevens talks about his plan to design a better structural element in streams on Wednesday at Paradise Creek Brewery.

The Palouse Conservation District (PCD) held a presentation about stream structure on Wednesday in the Paradise Creek Brewery Trailside Taproom.

Randy Stevens, PCD conservation coordinator, said changing stream structure can produce diverse habitats, which can help address drought and flooding.

He said reshaping stream structure can restore riparian zones, which are areas near streams, to healthy conditions.

This can be done in various ways, one of which being streambank bioengineering, Stevens said. This process includes using live and dead plant materials with natural and synthetic support materials. Streambank bioengineering helps control the streams behavior.

Stevens said using post-assisted log structures (PALS) can also change stream structure. This is a type of restoration technique where wood debris is planted in the stream.

PALS creates more water flow and increases the flow of sediment deposits, he said. These structures also create areas for species like salmon to lay eggs and raise their young.

He said more logs in the stream means there is more chance for the streams structure to become more complex.

The more complexity a stream has, the healthier it is thought to be, Stevens said.

Complex structures help build more resilience in the streams environment, he said. Streams become more functional as well, meaning more species will be able to live in the streams.

Stevens said stream complexity can also create refuge for wildlife by developing restoration areas near the streams.

If a stream lacks structure, this means a stream has a smooth system and the water flows in a straight manner, he said. This can be problematic. For example, if a flood occurs, fish can be easily swept away.

Another method to alter stream structure is the use of beaver dam analogs (BDAs), which are human-made designs that imitate natural beaver dams, Stevens said. BDAs collect a lot of debris that travel downstream, expands riparian vegetation and can change ecosystems rapidly.

He said changing stream structures to a more complex system is important because it helps improve the overall function of a stream. This includes drought resistance and reducing the severity of fire.

This also helps keep the water in the stream, which is important for aquifer recharge for groundwater levels.

Complex stream structures also mitigate the effects of flooding, he said.

Streams give the water a place to go, slow it down, and reduce that kind of thing from happening, Stevens said.

Some of the issues streams face include lack of water storage, which increases the effects of droughts, Stevens said. Lack of vegetation in and around the streams, lack of habitat for wildlife, and increased water temperature negatively affect the overall health of the stream.

Alison Crowley, PCD education and outreach as well as a restoration technician and AmeriCorps intern, said the public should care about this issue because the local area is surrounded by agriculture. She said it is important for individuals to bridge the gap between environmental awareness and how people operate within the environment.

Theyre a part of the issue, and theyre a part of the solution, she said.

Crowley said the PCD holds conservation talk series every second Wednesday of each month where the PCD discusses conservation practices they support and implement. They also talk about conservation efforts PCD has conducted.

The next PCD conservation talk is on March 11 from 6-7 p.m. in the Paradise Creek Brewery Trailside Taproom. The PCD will talk about conservation and native plants.

Originally posted here:
Reshaping stream structure to improve habitats - The Daily Evergreen

Biodecontamination market to register a CAGR of 6.1% from 2019 to 2024 – Yahoo Finance

Posted on by

Biodecontamination market to register a CAGR of 6.1% from 2019 to 2024.The biodecontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% from 2019 to 2024. The growth of the market is largely driven by the rising incidence of hospital-acquired infections (HAIs), growth in the pharmaceutical & biotechnology industries, and increasing outsourcing of biodecontamination services. Emerging economies are expected to provide a wide range of growth opportunities for players in the market.

NEW YORK, Jan. 23, 2020 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05786257/?utm_source=PRN

Equipment accounted for the major share of the market in 2019.By product & service, the biodecontamination market is segmented into equipment, consumables, and services.In 2018, the equipment segment accounted for the largest share of the market.

Services form the fastest-growing segment due to the low cost of services and low capital expenditure required, as compared to purchasing equipment & consumables.

Hydrogen peroxide accounted for the largest share of the biodecontamination market in 2019.On the basis of agent type, the biodecontamination market is segmented into hydrogen peroxide, nitrogen dioxide, chlorine dioxide, and peracetic acid.In 2018, the hydrogen peroxide segment accounted for the largest share of the biodecontamination market.

This segment is also expected to grow at the highest CAGR. Its material compatibility and safety are the major factors contributing to its dominance in the biodecontamination market.

Chamber biodecontamination accounted for the largest share of the biodecontamination market in 2019On the basis of type, the biodecontamination market is segmented into room and chamber biodecontamination.Chamber biodecontamination accounted for the largest share of the market in 2018 and is expected to show the highest growth during the forecast period.

This can be attributed to the lower power consumption, smaller footprint, high adaptation capabilities, and cost-effectiveness of chamber decontamination.

North America dominated the biodecontamination market in 2019.North America, which includes the US, & Canada, accounted for the largest share of the biodecontamination market in 2018. The growth in this market is primarily driven by the growing demand for biodecontamination from the healthcare industry to minimize the occurrence of HAIs, increasing healthcare expenditure, improved healthcare infrastructure, and the presence of major players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region: By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%) By Designation (Supply Side): C-level (35%), Director-level (45%), and Others (20%) By Region: North America (46%), Europe (28%), Asia (19%), and RoW (7%)

The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc. (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy). Product launches, expansions, agreements, and acquisitions are the key growth strategies followed by most players in this market.

Research CoverageThis report studies the biodecontamination market based on product & service, agent type, end user, and region.The report also analyzes factors (such as drivers, restraints, and opportunities) affecting market growth.

It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total biodecontamination market.

The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers: Market Penetration: Comprehensive information on biodecontamination offered by the top 12 players in the biodecontamination market. The report analyzes the biodecontamination market by product & services, type, agent type, end user, and region. Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for biodecontamination across key geographic regions. Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the biodecontamination market

Story continues

See the article here:
Biodecontamination market to register a CAGR of 6.1% from 2019 to 2024 - Yahoo Finance

Four books about the immigrant experience which are not American Dirt – AL DIA News

Posted on by

Described by celebrities such as Stephen King and Don Winslow as "The Grapes of Wrath of Our Time," Jeanine Cummins' book about a mother and son fleeing from the persecution of a drug cartel in Mexico has caused a stir in the Latino community, not only because of the media attention it has received but because of what they claim is a clich-laden account of the immigrant experience that masks a "whitewashing" in the book industry as well.

With no intention of continuing feeding thecontroversythe editorial blurb, we've decided to highlightbooks written by Latino authors that together make up a wide and rich range of the sentiment and harsh stories about migrants arriving in the United States.

Between novels and hybrid essays that deserve our full attention, these are our top picks:

Signs That Precede the End of the World

The second novel by Mexican writer Yuri Herrera is a display of narrative virtuosity with a female protagonist, Makina, a Mexican telephone operator who must undertake a dangerous journey to the United States in search of her brother.

A novel that reflects very well the migrant experience and the harshness of the border police, as well as describesthe life and speech of the border people shown through nine mythological journeys. Without any doubt, a book to delve into a Mexico of legends and also great sorrows, full of emotion and a universe of its own.

The Devil's Highway

Written more than 16 years ago by renowned Chicano poet and writer Luis Alberto Urrea, "The Devil's Highway" has become a nonfiction classic. It tells the story of 26 Mexican men who, in 2001, crossed the border into the inhospitable Arizona desert area known as Devil's Highway, facing many dangers, including the border patrol (La Migra), armed guards, rattlesnakes and the harshness of a bipolar climate - intense cold at night and relentless sunshine during the day -Urrea goes beyond the clichs, and reflects the absurdity of walls and migration policies in a book thatis totally up-to-date.

Tears of the Truffle-pig

Born in Mexico but raised in Texas, Fernando Flores has turned out to be one of the strangest and most revealing new voices of the past year, as has his unusual new weird dystopia, "Tears of the truffle-pig." Imagine a parallel universe, a South Texas in a strange dimension where drug trafficking is completely legal, but there is new contraband: extinct animal species that are raised through bioengineering. A surreal and hypnotic story dotted with legends about tribes and the mysterious cult of a Truffle Pig that is said to possess strange powers. A delirious, twisted and bold vision of the border that shows how inhumane border policy has become.

Borderlands/La Frontera: The New Mestiza

A mixture of essay, autobiography, and poetry, this jewel of Chicano activist Gloria Anzalda is as mestizo as its title. An essential work to understand the complexity of Chicano identity and a twist to the discourses on gender. What makes us border subjects? How many borders besides the physical ones shape us? Indigenous woman, lesbian, border dweller, this book not only addresses cultural mestizaje from Anzalda's own experience but is an x-ray of this identity flow that often causes confusion and even isolation to Latinos born in the United States or those who have grown up in the country.

The rest is here:
Four books about the immigrant experience which are not American Dirt - AL DIA News

Scientists Want to Explore Ocean With "Cyborg Jellyfish" – Futurism

Posted on by

A team of Stanford and Caltech scientists attached low-power microelectronics to the undersides of jellyfish to create biohybrid robots that swim three times as fast as normal ones.

The idea is to one day allow cyborg jellyfish, equipped with sensors, to explore the vast depths of our planets oceans rather than relying on unwieldy and inefficient submarines, Scientific American reports.

In a trial, the scientists were capable of using electrical jolts from microelectronic controllers to make jellyfish swim not only faster but also more efficiently,according to a paper published in Science Advances today.

Weve shown that theyre capable of moving much faster than they normally do, without an undue cost on their metabolism, said co-author and Stanford bioengineering PhD candidate Nicole Xu, in a statement.

This reveals that jellyfish possess an untapped ability for faster, more efficient swimming, Xu added. They just dont usually have a reason to do so.

Thanks to the simplicity of the design, the electronics use orders of magnitude less external power per mass than other aquatic robots, according to the paper.

The jellyfish cyborgs could revolutionize the way we explore the mysteries of the planets oceans. To do that, the researchers are already looking to take their project a step further by adding controls, using only a few modifications to the microelectronics.

If we can find a way to direct these jellyfish and also equip them with sensors to track things like ocean temperature, salinity, oxygen levels, and so on, we could create a truly global ocean network where each of the jellyfish robots costs a few dollars to instrument and feeds themselves energy from prey already in the ocean, said lead author and Caltech mechanical engineer John Dabiri.

READ MORE: Cyborg Jellyfish Could One Day Explore the Ocean [Scientific American]

More on cyborgs: This Biohacker Conference Sounds Absolutely Outrageous

See the rest here:
Scientists Want to Explore Ocean With "Cyborg Jellyfish" - Futurism